Accellacare - Wilmington
Wilmington, North Carolina, United States
Research institute in Winston-Salem, North Carolina
1901 S Hawthorne Rd #306, Winston-Salem, NC 27103
About Accellacare - Wilmington
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
15
BioNTech SE
3
Janssen Research & Development, LLC
2
Janssen Vaccines & Prevention B.V.
2
Evofem Inc.
1
Idorsia Pharmaceuticals Ltd.
1
RAI Services Company
1
Seqirus
1
Clinical Trials at Accellacare - Wilmington
During the past decade, Accellacare - Wilmington conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 8 clinical trials were completed, i.e. on
average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 8 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study
2019-04-01
2020-12-22
Completed
1,994
MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age
2020-06-17
2022-07-24
Completed
2,431
Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age
2020-09-01
2021-06-29
Completed
1,796
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
2020-10-15
2022-07-28
Active, not recruiting
1,730
A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants
2021-02-15
2021-07-22
Completed
1,574
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women
2022-08-12
2023-04-13
Active, not recruiting
53
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Accellacare - Wilmington" #1 sponsor was "Pfizer" with 15 trials, followed by "BioNTech SE" with 3 trials
sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored and "Evofem Inc."
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Accellacare - Wilmington"
#1 collaborator was "Pfizer" with 3 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Accellacare - Wilmington
According to Clinical.Site data, the most researched conditions in "Accellacare - Wilmington" are
"COVID-19" (8 trials), "SARS-CoV-2 Infection" (4 trials), "Pneumococcal Disease" (3 trials), "Influenza, Human" (2 trials) and "Chlamydia" (1 trials). Many other conditions were trialed in "Accellacare - Wilmington" in a lesser frequency.
Clinical Trials Intervention Types at Accellacare - Wilmington
Most popular intervention types in "Accellacare - Wilmington" are "Biological" (16 trials), "Drug" (9 trials) and "Other" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "BNT162b2" (3 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials) and "Saline" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Accellacare - Wilmington
The vast majority of trials in "Accellacare - Wilmington" are
24 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Accellacare - Wilmington
Currently, there are NaN active trials in "Accellacare - Wilmington".
undefined are not yet recruiting,
7 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Accellacare - Wilmington,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Accellacare - Wilmington, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".